Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

20.55 -0.96 (-4.46%)

Streaming Delayed Price Updated: 1:45 PM EST, Jan 5, 2026 Add to My Watchlist

Price and Volume

Volume	1,957,968
Open	21.61
Bid (Size)	20.54 (800)
Ask (Size)	20.56 (500)
Prev. Close	21.51
Today's Range	20.31 - 21.66
52wk Range	21.19 - 45.30
Shares Outstanding	308,456,852
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Arcutis Stock Is Up 100% in a Year but Here’s Why One Fund Still Sold 1 Million Shares ↗

December 23, 2025

Even after cutting back, this remains the fund’s largest bet and the timing lines up with a pivotal stretch for Arcutis’ pipeline.

Via The Motley Fool

Fund Discloses Increased Mineralys Bet Amid 200% Stock Run as New Drug Application Nears ↗

December 23, 2025

When a clinical-stage biotech is sitting on nearly $600 million in cash and lining up an FDA filing, sharp investors stop arguing about the past rally and start debating what comes next.

Via The Motley Fool

Performance

YTD	-4.5%	-4.5%
1 Month	-26.9%	-26.9%
3 Month	-34.6%	-34.6%
6 Month	-42.7%	-42.7%
1 Year	-40.8%	-40.8%

More News

Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 17, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

What to Expect from Legend Biotech's Earnings ↗

November 11, 2025

Via Benzinga

How Do Investors Really Feel About Legend Biotech? ↗

September 22, 2025

Via Benzinga

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

December 06, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

November 13, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights

November 12, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Considering Second Listing Outside US: Report ↗

September 05, 2025

Via Stocktwits

How Do Investors Really Feel About Legend Biotech? ↗

September 04, 2025

Via Benzinga

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

November 03, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Inside the Fintech Platform Winning Over a New Generation of Investors in Asia ↗

October 31, 2025

Via The Motley Fool

XP’s New Backer Sees Opportunity in Brazil’s Next Financial Chapter ↗

October 30, 2025

Via The Motley Fool

Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

October 29, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

AMD To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday ↗

October 17, 2025

Via Benzinga

Johnson & Johnson Stock Falls Premarket: Investors Eye MedTech Growth, Tariff Impact And Drug Pipeline In Q3 Print ↗

October 14, 2025

Via Stocktwits

Expert Outlook: Legend Biotech Through The Eyes Of 6 Analysts ↗

October 09, 2025

Via Benzinga

Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings

October 02, 2025

Via MarketMinute

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

August 26, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Legend Biotech Appoints Carlos Santos as Chief Financial Officer

August 18, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

The Analyst Verdict: Legend Biotech In The Eyes Of 5 Experts ↗

August 12, 2025

Via Benzinga

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Via MarketMinute

Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q2 2025 Earnings with Revenue Beat and EPS Miss Amid Strong CARVYKTI Sales ↗

August 11, 2025

Via Chartmill

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

August 11, 2025

From Legend Biotech USA Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Legend Biotech Corporation - American Depositary Shares publicly traded?

Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.

What exchange does Legend Biotech Corporation - American Depositary Shares trade on?

Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?

The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market

What is the current price of Legend Biotech Corporation - American Depositary Shares?

The current price of Legend Biotech Corporation - American Depositary Shares is 20.55

When was Legend Biotech Corporation - American Depositary Shares last traded?

The last trade of Legend Biotech Corporation - American Depositary Shares was at 01/05/26 01:45 PM ET

What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?

The market capitalization of Legend Biotech Corporation - American Depositary Shares is 6.34B

How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?

Legend Biotech Corporation - American Depositary Shares has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.